

Have you recently experienced mild fever, skin rash, or joint pain after traveling to an area with known outbreaks? You might have been exposed to the Zika virus — a mosquito-borne infection that can lead to serious complications, especially for pregnant women and their unborn babies.Zika virus tests, including IgM/IgG antibodies and PCR, are essential tools for detecting the infection in its early or late stages. In this article from Dalili Medical, we provide a clear, reliable overview of these tests — when they're ordered, what the results mean, and why they are particularly important for pregnant women and infants.
Zika virus belongs to the Flavivirus family and is primarily transmitted by the Aedes aegypti mosquito. However, it can also spread through sexual contact, blood transfusion, or from mother to fetus.
Mild fever
Skin rash
Joint and muscle pain
Conjunctivitis (red eyes)
Headache
Symptoms are typically mild and resolve within 2–7 days, but Zika during pregnancy can lead to serious birth defects, such as microcephaly.
These tests are recommended for:
✅ Individuals with flu-like symptoms who recently traveled to Zika-endemic regions
✅ Pregnant women exposed to mosquito bites or with infected partners
✅ Patients who had unprotected sex or blood transfusion from a possibly infected person
✅ Newborns showing neurological symptoms (risk of congenital abnormalities)
This test detects viral RNA in blood, urine, or other fluids.
Most effective in the first 7 days of infection
Considered the gold standard for early detection
Sample: Blood, urine, or cord blood (for pregnant women)
No fasting required
Results available within 24–48 hours
Appears 4–7 days after symptom onset
Remains positive for 2–12 weeks
Appears after 1–2 weeks of infection
May stay positive for life
IgM: Confirms recent or ongoing infection
IgG: Identifies previous exposure or immune response
PCR | IgM | IgG | Interpretation |
---|---|---|---|
+ | – | – | Very recent infection (antibodies not yet developed) |
+ | + | –/+ | Active/acute infection |
– | + | – | Recent infection after RNA clearance |
– | + | + | Ongoing or recent infection |
– | – | + | Past infection or immunity |
Zika during pregnancy can lead to:
Microcephaly
Severe brain damage
Growth and developmental delays
Regular fetal monitoring with ultrasound
Decisions about specialized care and management
Clear preventive guidance
A negative PCR doesn't rule out infection if tested after the first week
Positive IgM may cross-react with similar viruses (like Dengue)
Plaque Reduction Neutralization Test (PRNT) may be required to confirm Zika infection in complex cases
Vector Control and Personal Protection:
Wear long sleeves and mosquito-repellent-treated clothing
Use window screens or mosquito nets
Eliminate standing water to reduce mosquito breeding
Avoid unprotected sex if exposed or infected
Healthy adults: Usually mild illness
Pregnant women: High risk of congenital abnormalities
Newborns: Developmental delays, hearing loss, limb deformities
Yes. About 80% of infected individuals are asymptomatic.
No. Once recovered, your body develops long-term immunity, indicated by IgG antibodies.
No specific treatment exists. Management is supportive — rest, fluids, and treating symptoms.
Not yet. Several vaccines are under research, but none are currently approved.
Zika Virus PCR (for early detection) and IgM/IgG antibody tests (to identify timing of infection) are crucial tools in diagnosing Zika accurately — especially in pregnant women and high-risk groups.
Early diagnosis and proper monitoring can prevent complications and protect both the patient and the unborn baby.
If you're pregnant or suspect exposure to Zika, consult your doctor and ensure all test results are properly interpreted to safeguard your health and your baby’s future.